Questions? Call 800-624-6242
add to cart
Rights & Permissions
. "Appendix C: CDC Anthrax Vaccine Safety and Efficacy Research Plan." An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program. Washington, DC: The National Academies Press, 2002.
Please select a format:
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
the following areas:
Does the study design appear feasible?
Will the methods proposed answer the aims outlined for the KAB study?
Are the sampling strategies adequate and effective?
Is the longitudinal component well planned?
Are the components of cognitive testing, social desirability, and psychometric analysis sound?
Col. Gary D. Gackstetter, D.V.M., M.P.H., Ph.D.
Assistant Professor and Deputy Director
Uniformed Services University of the Health Sciences
Donald Hedeker, Ph.D.
Professor of Biostatistics, School of Public Health
University of Illinois at Chicago
Michael Puma, Ph.D.
Principal Research Associate
The Urban Institute, Washington DC
Michael Schwerin, Ph.D.
Navy Personnel Research Studies & Technology Dept
Institute for Organizational Assessment, Millington TN
Paul Levy, Sc.D.
Professor of Biostatistics & Epidemiology
School of Public Health